BioCryst Pharmaceuticals Inc Capital Reinvestment Ratio
BioCryst Pharmaceuticals Inc capital reinvestment ratio. BioCryst Pharmaceuticals Inc (BCRX) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($276.04 Million) in capital expenditures ($802.00K). See BCRX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BioCryst Pharmaceuticals Inc (2025–2025)
Capital reinvestment ratio of BioCryst Pharmaceuticals Inc from 2025 to 2025. This chart tracks BioCryst Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. See BioCryst Pharmaceuticals Inc (BCRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
BioCryst Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2025–2025)
BioCryst Pharmaceuticals Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of BioCryst Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $329.88 Million | $2.47 Million | — |